Search by Drug Name or NDC
NDC 69842-0680-10 Acetaminophen Aspirin Caffeine 250; 250; 65 mg/1; mg/1; mg/1 Details
Acetaminophen Aspirin Caffeine 250; 250; 65 mg/1; mg/1; mg/1
Acetaminophen Aspirin Caffeine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by CVS PHARMACY, INC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 69842-0680 |
|---|---|
| Product ID | 69842-680_0ce259b1-3dc4-177f-e063-6294a90a29d0 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Acetaminophen Aspirin Caffeine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen Aspirin Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | CVS PHARMACY, INC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214039 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69842-0680-10 (69842068010)
| NDC Package Code | 69842-680-10 |
|---|---|
| Billing NDC | 69842068010 |
| Package | 100 TABLET in 1 BOTTLE (69842-680-10) |
| Marketing Start Date | 2021-07-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |